To examine whether down-regulation of Mcl-1 is sufficient to sensitize glioma cells for ABT263-mediated apoptosis, we performed knock-down experiments targeting Mcl-1 in LN229 glioblastoma cells. The gene discussed is MCL1; the disease is central nervous system cancer.